Chicago Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-318,113
Closed -$7.6M 48
2021
Q1
$7.6M Buy
+318,113
New +$5.91M 3.54% 14

Chicago Capital Management's GNMK Position: Q2 2021 in Review

Chicago Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 318,113 shares — an estimated $7.6M sold.

Chicago Capital Management first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $7.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Chicago Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Chicago Capital Management sold 318,113 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $7.6M.
  • Chicago Capital Management first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • Chicago Capital Management's GenMark Diagnostics, Inc position peaked at $7.6M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Chicago Capital Management's 13F filing for Q2 2021, filed 11 Aug 2021.